We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Varicella-Zoster Virus in Giant Cell Arteritis—Reply

Maria A. Nagel, MD1; Teresa White, BS1; Don Gilden, MD1,2
[+] Author Affiliations
1Department of Neurology, University of Colorado School of Medicine, Aurora
2Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora
JAMA Neurol. 2016;73(2):239. doi:10.1001/jamaneurol.2015.3871.
Text Size: A A A
Published online


In Reply Regarding Almaghlouth and colleagues’ queries, our article1 noted that a patient was considered giant cell arteritis (GCA) negative when that patient had clinical features that led to a temporal artery (TA) biopsy but the biopsy did not reveal GCA pathology. Regarding aging, all participants, including control individuals, were older than 50 years, but only GCA-positive and GCA-negative participants had a significantly increased frequency of varicella-zoster virus (VZV) in their TAs. Regarding immunosuppression, while we were not privy to information regarding steroid treatment from deidentified patients outside our institution, virtually all TA biopsies performed at the University of Colorado were obtained before steroid treatment. Furthermore, while many control TAs were obtained from cadavers who had been immunosuppressed before death, VZV was detected in only 22% of these control TAs. Overall, there is no evidence that steroids or immunosuppression played a role in the significantly increased detection of VZV in 73% of GCA-positive and 64% of GCA-negative TAs.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2016
Ibrahim Almaghlouth, MBBS; Ismail Sari, MD; Robert D. Inman, MD, FRCPC, FRCP
1University of Toronto, Toronto Western Hospital, Department of Rheumatology, Toronto, Ontario, Canada
JAMA Neurol. 2016;73(2):238-239. doi:10.1001/jamaneurol.2015.3868.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...